Established role of bisphosphonate therapy for prevention of skeletal complications from myeloma bone disease

Evangelos Terpos; Meletios A Dimopoulos; James R. Berenson

doi:10.1016/s1040-8428(11)70004-x

Related publications

Article2012

Prevention and Treatment of Myeloma Bone Disease

Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos

Article2019

Myeloma bone disease: from biology findings to treatment approaches

Evangelos Terpos, Ioannis Ntanasis‐Stathopoulos, Meletios A Dimopoulos

Article2021

Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group

Evangelos Terpos, Elena Zamagni, Suzanne Lentzsch, Matthew T. Drake, Ramón García‐Sánz, Niels Abildgaard, Ioannis Ntanasis‐Stathopoulos, Fredrik Schjesvold, Javier de la Rubia, Charalampia Kyriakou, Jens Hillengaß, Sonja Zweegman, Michèle Cavo, Philippe Moreau, Jesús F. San Miguel, Meletios A Dimopoulos, Nikhil C. Munshi, Brian G.M. Durie, Noopur Raje

Article2017

Emerging treatment approaches for myeloma-related bone disease

Maria Gavriatopoulou, Meletios A Dimopoulos, Efstathios Kastritis, Evangelos Terpos

Letter2018

Denosumab for myeloma bone disease: ready for prime time?

Meletios A Dimopoulos, Efstathios Kastritis